L

Lord Vallance of Balham (Lab)

Speaking in the House of Lords on 6 February 2025

Debate

AstraZeneca

Contribution

I thank my noble friend for her question. The UK is fortunate to have two very large pharmaceutical companies in this land, and we have many biotechs starting up as a result, because many of the people in those biotechs were trained in the big companies. As my noble friend quite rightly points out, the relationship with the NHS is important. All of these things create an ecosystem for life sciences investment which we are very keen to continue. The history of state-run manufacturing facilities is not one that generally leads to advanced manufacturing and efficiency.

More from Lord Vallance of Balham (Lab)

Other recent Hansard contributions by the same speaker.

About Hansard

Hansard is the official verbatim record of proceedings in the UK Parliament. Every word spoken in the Commons and Lords is recorded and published — this page is a single contribution from that record.

Partner sites